Related Experiment Videos

Antimicrobial susceptibility of Pneumocystis carinii in culture

Insights

Metronidazole was ineffective against Pneumocystis carinii. Amphotericin B showed some effect, while miconazole, chloroquine, trimethoprim-sulfamethoxazole, and pentamidine isethionate effectively suppressed these organisms in vitro.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Antimicrobial Research

Background:

  • Pneumocystis carinii is an opportunistic pathogen causing pneumonia in immunocompromised individuals.
  • Effective in vitro antimicrobial susceptibility testing is crucial for guiding clinical treatment strategies.
  • WI-38 human lung fibroblasts provide a relevant model for studying P. carinii interactions.

Purpose of the Study:

  • To evaluate the in vitro efficacy of various antimicrobial agents against Pneumocystis carinii.
  • To determine the minimum inhibitory concentrations or effective concentrations of selected drugs.
  • To identify potential therapeutic options for Pneumocystis pneumonia.

Main Methods:

  • Culturing Pneumocystis carinii isolated from infected rats on WI-38 human lung fibroblasts.
  • Exposing established cultures to different concentrations of antimicrobial agents.
  • Quantifying viable Pneumocystis carinii organisms in culture supernatants over time.

Main Results:

  • Metronidazole demonstrated no significant inhibitory effect on Pneumocystis carinii growth.
  • Amphotericin B exhibited suppressive activity at 5 microgram/ml but not at 0.5 microgram/ml.
  • Miconazole, chloroquine, trimethoprim-sulfamethoxazole, and pentamidine isethionate effectively suppressed organism growth at tested concentrations.

Conclusions:

  • Several antimicrobial agents show promise for treating P. carinii infections.
  • Trimethoprim-sulfamethoxazole and pentamidine isethionate are confirmed effective in vitro.
  • Further investigation into amphotericin B's efficacy at varying concentrations is warranted.

Related Concept Videos